| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.727 | 0.004 | 0.727 | Antihistaminic | 0.704 0.004 DBMET03080 0.123 0.041 DBMET03081 | ||
| 0.722 | 0.004 | 0.722 | Histamine antagonist | 0.702 0.004 DBMET03080 0.108 0.044 DBMET03081 | ||
| 0.553 | 0.003 | 0.553 | Histamine H3 receptor antagonist | 0.056 0.023 DBMET03080 | ||
| 0.539 | 0.012 | 0.794 | HERG channel blocker | 0.794 0.004 DBMET03080 | DBMET03080 | |
| 0.527 | 0.004 | 0.634 | Histamine H1 receptor antagonist | 0.634 0.003 DBMET03080 0.17 0.019 DBMET03081 | DBMET03080 | |
| 0.513 | 0.013 | 0.752 | Potassium channel (Voltage-sensitive) blocker | 0.752 0.005 DBMET03080 | DBMET03080 | |
| 0.5 | 0.027 | 0.507 | 5 Hydroxytryptamine release stimulant | 0.211 0.113 DBMET03080 0.507 0.026 DBMET03081 | DBMET03081 | |
| 0.504 | 0.032 | 0.742 | Cholesterol antagonist | 0.324 0.077 DBMET03080 0.742 0.005 DBMET03081 | DBMET03081 | |
| 0.479 | 0.012 | 0.479 | Sigma receptor agonist | 0.15 0.085 DBMET03080 | ||
| 0.45 | 0.016 | 0.45 | Anticonvulsant | 0.281 0.046 DBMET03081 | ||
| 0.458 | 0.029 | 0.509 | Spasmolytic | 0.509 0.022 DBMET03080 0.46 0.029 DBMET03081 | DBMET03080 | |
| 0.434 | 0.018 | 0.519 | Psychostimulant | 0.199 0.08 DBMET03080 0.519 0.009 DBMET03081 | DBMET03081 | |
| 0.431 | 0.018 | 0.649 | Potassium channel blocker | 0.649 0.005 DBMET03080 | DBMET03080 | |
| 0.414 | 0.005 | 0.414 | Neurotrophic factor | 0.237 0.015 DBMET03080 0.289 0.009 DBMET03081 | ||
| 0.409 | 0.007 | 0.409 | Nav1.2 sodium channel blocker | 0.124 0.078 DBMET03080 0.27 0.019 DBMET03081 | ||
| 0.449 | 0.051 | 0.49 | Histamine release inhibitor | 0.49 0.032 DBMET03081 | DBMET03081 | |
| 0.402 | 0.024 | 0.402 | Calcium channel activator | 0.277 0.116 DBMET03080 0.313 0.079 DBMET03081 | ||
| 0.376 | 0.02 | 0.429 | Anesthetic general | 0.161 0.103 DBMET03080 0.429 0.013 DBMET03081 | DBMET03081 | |
| 0.393 | 0.038 | 0.433 | Vasodilator, coronary | 0.244 0.14 DBMET03080 0.433 0.027 DBMET03081 | DBMET03081 | |
| 0.42 | 0.066 | 0.42 | 5 Hydroxytryptamine release inhibitor | 0.262 0.211 DBMET03080 0.37 0.099 DBMET03081 | ||
| 0.357 | 0.006 | 0.357 | Nav1.3 sodium channel blocker | 0.196 0.026 DBMET03081 | ||
| 0.348 | 0.005 | 0.348 | Sigma receptor antagonist | |||
| 0.338 | 0.003 | 0.338 | Histamine N-methyltransferase inhibitor | 0.149 0.015 DBMET03080 0.109 0.038 DBMET03081 | ||
| 0.384 | 0.054 | 0.599 | Antithrombotic | 0.192 0.187 DBMET03080 0.599 0.016 DBMET03081 | DBMET03081 | |
| 0.336 | 0.01 | 0.336 | Acetylcholine M1 receptor antagonist | 0.181 0.051 DBMET03080 0.177 0.054 DBMET03081 | ||
| 0.391 | 0.069 | 0.391 | Antiobesity | 0.302 0.115 DBMET03080 0.304 0.113 DBMET03081 | ||
| 0.31 | 0.004 | 0.31 | Dopamine uptake inhibitor | 0.066 0.033 DBMET03080 | ||
| 0.337 | 0.033 | 0.413 | Interleukin agonist | 0.194 0.126 DBMET03080 0.413 0.017 DBMET03081 | DBMET03081 | |
| 0.311 | 0.009 | 0.311 | Calcium channel blocker | 0.149 0.059 DBMET03081 | ||
| 0.316 | 0.015 | 0.316 | 5 Hydroxytryptamine 2 antagonist | 0.17 0.038 DBMET03080 | ||
| 0.312 | 0.011 | 0.312 | Anesthetic local | 0.099 0.083 DBMET03080 0.206 0.031 DBMET03081 | ||
| 0.31 | 0.034 | 0.31 | Ca(v)3.3 blocker | 0.25 0.1 DBMET03081 | ||
| 0.294 | 0.02 | 0.294 | Neurotrophic factor enhancer | 0.171 0.109 DBMET03080 0.198 0.079 DBMET03081 | ||
| 0.288 | 0.015 | 0.288 | Cholinergic antagonist | 0.175 0.04 DBMET03080 0.136 0.061 DBMET03081 | ||
| 0.331 | 0.059 | 0.331 | Aldehyde oxidase inhibitor | 0.187 0.112 DBMET03081 | ||
| 0.277 | 0.006 | 0.277 | Calcium antagonist | 0.131 0.03 DBMET03080 0.225 0.011 DBMET03081 | ||
| 0.28 | 0.011 | 0.28 | Dopamine D2 antagonist | 0.097 0.033 DBMET03080 | ||
| 0.283 | 0.015 | 0.283 | Acetylcholine antagonist | 0.128 0.064 DBMET03080 0.129 0.063 DBMET03081 | ||
| 0.276 | 0.011 | 0.276 | Acetylcholine muscarinic antagonist | 0.138 0.052 DBMET03080 0.139 0.051 DBMET03081 | ||
| 0.297 | 0.032 | 0.297 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.275 | 0.013 | 0.275 | Dopamine antagonist | 0.14 0.027 DBMET03080 | ||
| 0.266 | 0.004 | 0.266 | Sigma 1 receptor antagonist | |||
| 0.264 | 0.003 | 0.264 | Sigma 2 receptor antagonist | 0.03 0.017 DBMET03080 | ||
| 0.259 | 0.004 | 0.259 | Histamine H2 receptor antagonist | 0.102 0.033 DBMET03080 0.119 0.021 DBMET03081 | ||
| 0.266 | 0.012 | 0.266 | Toll-Like receptor antagonist | |||
| 0.292 | 0.037 | 0.316 | Tyrosine 3 hydroxylase inhibitor | 0.218 0.107 DBMET03080 0.316 0.026 DBMET03081 | DBMET03081 | |
| 0.267 | 0.013 | 0.267 | 5 Hydroxytryptamine 2A antagonist | 0.142 0.03 DBMET03080 | ||
| 0.268 | 0.017 | 0.268 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.304 | 0.054 | 0.339 | Cardiotonic | 0.339 0.042 DBMET03080 0.297 0.057 DBMET03081 | DBMET03080 | |
| 0.258 | 0.022 | 0.258 | Antipruritic | 0.234 0.03 DBMET03080 0.249 0.025 DBMET03081 | ||
| 0.283 | 0.054 | 0.446 | 5 Hydroxytryptamine uptake stimulant | 0.223 0.112 DBMET03080 0.446 0.008 DBMET03081 | DBMET03081 | |
| 0.316 | 0.089 | 0.53 | Vasodilator, peripheral | 0.53 0.023 DBMET03081 | DBMET03081 | |
| 0.237 | 0.023 | 0.237 | 5 Hydroxytryptamine 3E antagonist | 0.176 0.117 DBMET03080 | ||
| 0.354 | 0.142 | 0.407 | Caspase 9 stimulant | 0.407 0.107 DBMET03081 | DBMET03081 | |
| 0.326 | 0.122 | 0.357 | Analgesic | 0.357 0.105 DBMET03080 | DBMET03080 | |
| 0.253 | 0.05 | 0.253 | ErbB-1 antagonist | |||
| 0.216 | 0.014 | 0.216 | Neuropeptide Y1 antagonist | 0.126 0.11 DBMET03080 0.158 0.054 DBMET03081 | ||
| 0.207 | 0.009 | 0.207 | Multidrug resistance-associated protein 1 inhibitor | 0.131 0.037 DBMET03080 0.129 0.039 DBMET03081 | ||
| 0.219 | 0.021 | 0.273 | Antiadrenergic | 0.273 0.015 DBMET03080 0.084 0.068 DBMET03081 | DBMET03080 | |
| 0.21 | 0.016 | 0.21 | Nav1.6 sodium channel blocker | 0.114 0.105 DBMET03081 | ||
| 0.215 | 0.021 | 0.269 | Adrenaline antagonist | 0.269 0.015 DBMET03080 0.081 0.067 DBMET03081 | DBMET03080 | |
| 0.259 | 0.069 | 0.299 | Gastrin inhibitor | 0.299 0.034 DBMET03081 | DBMET03081 | |
| 0.208 | 0.017 | 0.463 | Bronchodilator | 0.463 0.005 DBMET03080 0.254 0.013 DBMET03081 | DBMET03080 | |
| 0.206 | 0.018 | 0.206 | Nav1.1 sodium channel blocker | 0.112 0.054 DBMET03081 | ||
| 0.216 | 0.03 | 0.216 | 5 Hydroxytryptamine antagonist | |||
| 0.212 | 0.026 | 0.215 | Alpha adrenoreceptor antagonist | 0.215 0.025 DBMET03080 | DBMET03080 | |
| 0.19 | 0.005 | 0.19 | Acetylcholine M5 receptor antagonist | 0.075 0.027 DBMET03080 | ||
| 0.2 | 0.017 | 0.2 | Calcium channel (voltage-sensitive) blocker | |||
| 0.197 | 0.016 | 0.197 | 5 Hydroxytryptamine 3A agonist | |||
| 0.183 | 0.003 | 0.183 | Sphingosine kinase 2 inhibitor | 0.089 0.011 DBMET03080 0.064 0.027 DBMET03081 | ||
| 0.236 | 0.059 | 0.409 | Platelet aggregation inhibitor | 0.409 0.017 DBMET03081 | DBMET03081 | |
| 0.216 | 0.04 | 0.238 | Cholinergic | 0.238 0.032 DBMET03080 | DBMET03080 | |
| 0.188 | 0.012 | 0.188 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.232 | 0.059 | 0.232 | DNA methylase inhibitor | 0.167 0.103 DBMET03081 | ||
| 0.183 | 0.014 | 0.183 | Dopamine D4 antagonist | 0.065 0.039 DBMET03080 | ||
| 0.221 | 0.052 | 0.221 | P-glycoprotein inhibitor | 0.169 0.09 DBMET03081 | ||
| 0.187 | 0.018 | 0.189 | Sphingosine 1-phosphate receptor 5 antagonist | 0.189 0.017 DBMET03081 | DBMET03081 | |
| 0.174 | 0.007 | 0.174 | Calcium channel L-type blocker | 0.1 0.024 DBMET03081 | ||
| 0.313 | 0.146 | 0.313 | Calcium channel L-type activator | 0.253 0.202 DBMET03080 0.262 0.193 DBMET03081 | ||
| 0.188 | 0.023 | 0.211 | Alpha 1 adrenoreceptor antagonist | 0.211 0.019 DBMET03080 | DBMET03080 | |
| 0.191 | 0.026 | 0.191 | Alpha 2b adrenoreceptor antagonist | 0.095 0.08 DBMET03080 | ||
| 0.167 | 0.004 | 0.167 | Histamine agonist | 0.047 0.046 DBMET03080 0.051 0.038 DBMET03081 | ||
| 0.17 | 0.008 | 0.17 | Acetylcholine M4 receptor antagonist | 0.096 0.031 DBMET03080 | ||
| 0.191 | 0.029 | 0.191 | Cholesterol synthesis inhibitor | 0.097 0.091 DBMET03080 0.185 0.031 DBMET03081 | ||
| 0.177 | 0.015 | 0.177 | Sphingomyelinase inhibitor | 0.086 0.078 DBMET03080 0.131 0.034 DBMET03081 | ||
| 0.169 | 0.009 | 0.169 | Acetylcholine release stimulant | 0.112 0.063 DBMET03080 | ||
| 0.179 | 0.02 | 0.179 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.168 | 0.011 | 0.247 | Adrenaline agonist | 0.247 0.005 DBMET03081 | DBMET03081 | |
| 0.166 | 0.009 | 0.166 | Acetylcholine M3 receptor antagonist | 0.055 0.048 DBMET03080 0.059 0.043 DBMET03081 | ||
| 0.203 | 0.047 | 0.417 | Succinate dehydrogenase inhibitor | 0.186 0.061 DBMET03080 0.417 0.004 DBMET03081 | DBMET03081 | |
| 0.181 | 0.027 | 0.245 | Cyclooxygenase 3 inhibitor | 0.138 0.059 DBMET03080 0.245 0.009 DBMET03081 | DBMET03081 | |
| 0.158 | 0.004 | 0.158 | Sphingosine kinase inhibitor | 0.072 0.022 DBMET03080 0.087 0.012 DBMET03081 | ||
| 0.167 | 0.017 | 0.167 | Acetylcholine nicotinic antagonist | 0.089 0.046 DBMET03080 0.087 0.048 DBMET03081 | ||
| 0.279 | 0.13 | 0.28 | GABA C receptor rho-3 antagonist | 0.28 0.13 DBMET03081 | DBMET03081 | |
| 0.168 | 0.02 | 0.258 | NMDA receptor antagonist | 0.258 0.009 DBMET03081 | DBMET03081 | |
| 0.147 | 0.002 | 0.147 | GABA uptake inhibitor | 0.065 0.008 DBMET03080 0.072 0.006 DBMET03081 | ||
| 0.167 | 0.023 | 0.232 | Sphingosine 1-phosphate receptor 2 antagonist | 0.232 0.004 DBMET03081 | DBMET03081 | |
| 0.226 | 0.083 | 0.298 | Antiamyloidogenic | 0.157 0.138 DBMET03080 0.298 0.052 DBMET03081 | DBMET03081 | |
| 0.182 | 0.039 | 0.218 | Acetylcholinesterase inhibitor | 0.218 0.028 DBMET03080 | DBMET03080 | |
| 0.152 | 0.01 | 0.152 | Interferon agonist | 0.136 0.013 DBMET03081 | ||
| 0.154 | 0.014 | 0.154 | Dopamine D1 antagonist | 0.085 0.03 DBMET03080 | ||
| 0.148 | 0.008 | 0.148 | Nicotinic alpha4beta2 receptor antagonist | 0.11 0.024 DBMET03080 | ||
| 0.167 | 0.028 | 0.167 | Butyrylcholinesterase inhibitor | 0.144 0.036 DBMET03080 | ||
| 0.149 | 0.012 | 0.149 | Lanosterol 14 alpha demethylase inhibitor | 0.094 0.065 DBMET03080 0.131 0.021 DBMET03081 | ||
| 0.147 | 0.011 | 0.147 | Acetylcholine M2 receptor antagonist | |||
| 0.227 | 0.091 | 0.269 | Superoxide dismutase inhibitor | 0.269 0.064 DBMET03081 | DBMET03081 | |
| 0.202 | 0.068 | 0.202 | DNA methyltransferase I inhibitor | 0.14 0.116 DBMET03081 | ||
| 0.156 | 0.023 | 0.184 | Alpha 1a adrenoreceptor antagonist | 0.184 0.018 DBMET03080 | DBMET03080 | |
| 0.239 | 0.107 | 0.368 | Insulysin inhibitor | 0.368 0.029 DBMET03081 | DBMET03081 | |
| 0.147 | 0.015 | 0.147 | Cannabinoid receptor antagonist | |||
| 0.136 | 0.005 | 0.136 | Potassium channel intermediate-conductance Ca-activated blocker | 0.06 0.042 DBMET03080 | ||
| 0.147 | 0.015 | 0.147 | Dopamine agonist | |||
| 0.138 | 0.009 | 0.138 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.139 | 0.011 | 0.139 | Acetylcholine muscarinic agonist | 0.054 0.039 DBMET03080 | ||
| 0.142 | 0.016 | 0.142 | Dopamine D3 antagonist | 0.086 0.03 DBMET03080 | ||
| 0.129 | 0.004 | 0.129 | Nicotinic alpha3beta2 receptor antagonist | 0.097 0.008 DBMET03080 | ||
| 0.144 | 0.023 | 0.144 | Alpha 1b adrenoreceptor antagonist | |||
| 0.16 | 0.039 | 0.205 | Antibacterial (Helicobacter pylori) | 0.205 0.02 DBMET03081 | DBMET03081 | |
| 0.129 | 0.009 | 0.129 | Acetylcholine M1 receptor agonist | 0.041 0.031 DBMET03080 | ||
| 0.151 | 0.032 | 0.151 | Alpha 2c adrenoreceptor antagonist | |||
| 0.129 | 0.01 | 0.129 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.178 | 0.058 | 0.178 | Cytidine deaminase inhibitor | |||
| 0.261 | 0.142 | 0.261 | Calpain 2 inhibitor | 0.217 0.173 DBMET03081 | ||
| 0.124 | 0.005 | 0.124 | Histamine H3 receptor agonist | 0.029 0.018 DBMET03080 | ||
| 0.121 | 0.004 | 0.121 | Sphingosine kinase 1 inhibitor | 0.046 0.02 DBMET03080 0.047 0.019 DBMET03081 | ||
| 0.313 | 0.196 | 0.313 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.145 | 0.027 | 0.145 | Acetylcholine agonist | |||
| 0.153 | 0.036 | 0.153 | Ca2+-transporting ATPase inhibitor | 0.13 0.121 DBMET03080 0.145 0.056 DBMET03081 | ||
| 0.147 | 0.03 | 0.147 | Mediator release inhibitor | 0.141 0.033 DBMET03081 | ||
| 0.13 | 0.015 | 0.151 | Epoxide hydrolase inhibitor | 0.151 0.011 DBMET03081 | DBMET03081 | |
| 0.172 | 0.058 | 0.412 | Phospholipase A2 inhibitor | 0.412 0.005 DBMET03081 | DBMET03081 | |
| 0.118 | 0.008 | 0.118 | Interferon inducer | 0.098 0.013 DBMET03081 | ||
| 0.233 | 0.123 | 0.259 | Nootropic | 0.259 0.1 DBMET03080 | DBMET03080 | |
| 0.12 | 0.011 | 0.12 | Acetylcholine M5 receptor agonist | |||
| 0.208 | 0.099 | 0.312 | Vasodilator | 0.312 0.044 DBMET03081 | DBMET03081 | |
| 0.11 | 0.004 | 0.11 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.088 0.004 DBMET03080 0.041 0.019 DBMET03081 | ||
| 0.117 | 0.012 | 0.117 | Cannabinoid CB1 receptor antagonist | |||
| 0.145 | 0.041 | 0.145 | Calcium channel N-type blocker | |||
| 0.167 | 0.063 | 0.256 | Diuretic | 0.256 0.03 DBMET03081 | DBMET03081 | |
| 0.111 | 0.009 | 0.111 | Dopamine D2 agonist | 0.042 0.033 DBMET03081 | ||
| 0.126 | 0.024 | 0.126 | 5 Hydroxytryptamine 1A antagonist | |||
| 0.106 | 0.005 | 0.106 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.152 | 0.051 | 0.286 | Toll-Like receptor 2 antagonist | 0.286 0.005 DBMET03081 | DBMET03081 | |
| 0.169 | 0.068 | 0.199 | Catenin beta inhibitor | 0.199 0.032 DBMET03081 | DBMET03081 | |
| 0.17 | 0.07 | 0.17 | ATPase inhibitor | 0.134 0.133 DBMET03081 | ||
| 0.112 | 0.012 | 0.112 | CC chemokine 5 receptor agonist | |||
| 0.166 | 0.068 | 0.261 | Neurotensin receptor agonist | 0.261 0.019 DBMET03081 | DBMET03081 | |
| 0.206 | 0.109 | 0.222 | Neuropeptide Y2 antagonist | 0.222 0.086 DBMET03081 | DBMET03081 | |
| 0.247 | 0.15 | 0.405 | Immunosuppressant | 0.405 0.06 DBMET03081 | DBMET03081 | |
| 0.108 | 0.011 | 0.179 | NMDA 2A receptor antagonist | 0.179 0.005 DBMET03081 | DBMET03081 | |
| 0.109 | 0.013 | 0.109 | Cannabinoid CB2 receptor antagonist | |||
| 0.139 | 0.044 | 0.201 | Sphingosine 1-phosphate receptor 4 antagonist | 0.201 0.009 DBMET03081 | DBMET03081 | |
| 0.168 | 0.075 | 0.168 | Mcl-1 antagonist | 0.14 0.1 DBMET03081 | ||
| 0.196 | 0.104 | 0.514 | Platelet antagonist | 0.514 0.013 DBMET03081 | DBMET03081 | |
| 0.179 | 0.089 | 0.222 | Amyloid beta aggregation inhibitor | 0.222 0.067 DBMET03081 | DBMET03081 | |
| 0.12 | 0.03 | 0.12 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.17 | 0.081 | 0.17 | Amyloid beta precursor protein antagonist | |||
| 0.092 | 0.003 | 0.092 | Heme oxygenase inhibitor | 0.053 0.01 DBMET03080 0.042 0.032 DBMET03081 | ||
| 0.114 | 0.026 | 0.114 | Glutamate release inhibitor | 0.097 0.048 DBMET03081 | ||
| 0.15 | 0.063 | 0.15 | Toll-Like receptor 9 antagonist | |||
| 0.189 | 0.102 | 0.189 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.129 | 0.045 | 0.129 | Transcription factor STAT6 inhibitor | |||
| 0.105 | 0.023 | 0.105 | Caspase 7 inhibitor | 0.085 0.051 DBMET03081 | ||
| 0.103 | 0.022 | 0.103 | Viral attachment inhibitor | |||
| 0.108 | 0.028 | 0.117 | NMDA 2 receptor antagonist | 0.117 0.025 DBMET03081 | DBMET03081 | |
| 0.27 | 0.191 | 0.469 | Cyclophilin D inhibitor | 0.469 0.06 DBMET03081 | DBMET03081 | |
| 0.085 | 0.007 | 0.115 | Beta 2 adrenoreceptor agonist | 0.058 0.057 DBMET03080 0.115 0.004 DBMET03081 | DBMET03081 | |
| 0.087 | 0.01 | 0.087 | Calcium channel P-type blocker | 0.06 0.057 DBMET03080 | ||
| 0.157 | 0.08 | 0.207 | Arachidonic acid antagonist | 0.207 0.027 DBMET03081 | DBMET03081 | |
| 0.143 | 0.067 | 0.143 | Pregnane X receptor agonist | |||
| 0.224 | 0.151 | 0.415 | Interleukin 2 agonist | 0.201 0.188 DBMET03080 0.415 0.023 DBMET03081 | DBMET03081 | |
| 0.143 | 0.071 | 0.143 | MAP3K9 inhibitor | |||
| 0.082 | 0.012 | 0.11 | Epithelial sodium channel blocker | 0.11 0.005 DBMET03081 | DBMET03081 | |
| 0.079 | 0.009 | 0.079 | Histamine H4 receptor antagonist | |||
| 0.098 | 0.029 | 0.098 | Estrogen receptor alpha antagonist | |||
| 0.071 | 0.003 | 0.071 | Ceramide glucosyltransferase inhibitor | 0.035 0.025 DBMET03080 0.045 0.01 DBMET03081 | ||
| 0.076 | 0.009 | 0.102 | Leukotriene A4 hydrolase inhibitor | 0.102 0.005 DBMET03081 | DBMET03081 | |
| 0.114 | 0.048 | 0.184 | Gastric antisecretory | 0.184 0.015 DBMET03081 | DBMET03081 | |
| 0.131 | 0.065 | 0.198 | Vanilloid 1 agonist | 0.198 0.012 DBMET03081 | DBMET03081 | |
| 0.087 | 0.021 | 0.087 | 5 Hydroxytryptamine 2A agonist | |||
| 0.09 | 0.026 | 0.09 | Alpha 1d adrenoreceptor antagonist | |||
| 0.087 | 0.023 | 0.087 | Adrenaline uptake inhibitor | 0.07 0.034 DBMET03080 | ||
| 0.114 | 0.05 | 0.123 | Toll-Like receptor 4 antagonist | 0.123 0.041 DBMET03081 | DBMET03081 | |
| 0.072 | 0.009 | 0.072 | Cholesterol esterase inhibitor | 0.048 0.033 DBMET03081 | ||
| 0.087 | 0.025 | 0.087 | Phospholipase D inhibitor | 0.081 0.032 DBMET03081 | ||
| 0.081 | 0.02 | 0.311 | Thromboxane antagonist | 0.311 0.003 DBMET03081 | DBMET03081 | |
| 0.098 | 0.037 | 0.098 | Alpha 2a adrenoreceptor antagonist | |||
| 0.086 | 0.025 | 0.086 | Cannabinoid CB1 receptor agonist | 0.055 0.048 DBMET03081 | ||
| 0.164 | 0.104 | 0.164 | MAP kinase kinase 5 inhibitor | |||
| 0.072 | 0.015 | 0.072 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.093 | 0.036 | 0.093 | 5 Hydroxytryptamine agonist | 0.079 0.042 DBMET03080 | ||
| 0.075 | 0.019 | 0.075 | Dopamine transporter inhibitor | |||
| 0.067 | 0.011 | 0.067 | CC chemokine 4 receptor antagonist | |||
| 0.102 | 0.047 | 0.102 | Toll-Like receptor 3 antagonist | |||
| 0.064 | 0.01 | 0.064 | Cytokine production stimulant | |||
| 0.069 | 0.015 | 0.124 | Dopamine D5 antagonist | 0.124 0.008 DBMET03080 | DBMET03080 | |
| 0.077 | 0.024 | 0.077 | MDM2 inhibitor | 0.077 0.024 DBMET03081 | ||
| 0.077 | 0.024 | 0.077 | Calcium channel T-type blocker | |||
| 0.072 | 0.02 | 0.277 | Thromboxane A2 antagonist | 0.277 0.003 DBMET03081 | DBMET03081 | |
| 0.123 | 0.072 | 0.166 | Cathepsin H inhibitor | 0.166 0.036 DBMET03081 | DBMET03081 | |
| 0.136 | 0.085 | 0.17 | Thiol protease inhibitor | 0.17 0.054 DBMET03081 | DBMET03081 | |
| 0.099 | 0.049 | 0.099 | Alpha 2 adrenoreceptor antagonist | |||
| 0.083 | 0.033 | 0.083 | Neuronal nicotinic receptor antagonist | |||
| 0.066 | 0.018 | 0.091 | Leukotriene C antagonist | 0.091 0.005 DBMET03081 | DBMET03081 | |
| 0.104 | 0.055 | 0.104 | Creatine kinase inhibitor | |||
| 0.083 | 0.035 | 0.101 | Amidase inhibitor | 0.101 0.024 DBMET03081 | DBMET03081 | |
| 0.066 | 0.018 | 0.066 | Prolyl endopeptidase inhibitor | |||
| 0.065 | 0.018 | 0.075 | Oleamide hydrolase inhibitor | 0.075 0.014 DBMET03081 | DBMET03081 | |
| 0.151 | 0.105 | 0.491 | Phospholipase C inhibitor | 0.491 0.006 DBMET03081 | DBMET03081 | |
| 0.108 | 0.063 | 0.108 | Falcipain 3 inhibitor | |||
| 0.136 | 0.09 | 0.184 | Adenylate cyclase stimulant | 0.184 0.023 DBMET03081 | DBMET03081 | |
| 0.179 | 0.133 | 0.422 | Immunostimulant | 0.422 0.044 DBMET03081 | DBMET03081 | |
| 0.064 | 0.018 | 0.064 | CC chemokine 3 receptor antagonist | |||
| 0.063 | 0.018 | 0.063 | Squalene epoxidase inhibitor | 0.047 0.04 DBMET03081 | ||
| 0.136 | 0.091 | 0.158 | Heat shock protein 70 antagonist | 0.158 0.031 DBMET03081 | DBMET03081 | |
| 0.089 | 0.046 | 0.089 | Opioid kappa receptor antagonist | |||
| 0.079 | 0.036 | 0.079 | Potassium channel (Tandem pore domain) blocker | |||
| 0.099 | 0.057 | 0.099 | Prolactin inhibitor | |||
| 0.054 | 0.012 | 0.1 | Beta adrenoreceptor agonist | 0.1 0.004 DBMET03081 | DBMET03081 | |
| 0.078 | 0.038 | 0.289 | Sphingosine 1-phosphate receptor 4 agonist | 0.289 0.003 DBMET03081 | DBMET03081 | |
| 0.088 | 0.047 | 0.088 | Acetylcholine nicotinic agonist | |||
| 0.075 | 0.034 | 0.075 | 5 Hydroxytryptamine 7 antagonist | |||
| 0.105 | 0.066 | 0.105 | DOPA decarboxylase inhibitor | 0.103 0.071 DBMET03081 | ||
| 0.219 | 0.18 | 0.329 | Toll-Like receptor agonist | 0.329 0.094 DBMET03081 | DBMET03081 | |
| 0.071 | 0.032 | 0.096 | NMDA 2C receptor antagonist | 0.096 0.017 DBMET03081 | DBMET03081 | |
| 0.062 | 0.024 | 0.062 | CC chemokine 5 receptor antagonist | |||
| 0.05 | 0.012 | 0.05 | Acetylcholine M4 receptor agonist | |||
| 0.054 | 0.016 | 0.054 | Thymidine kinase inhibitor | 0.039 0.032 DBMET03081 | ||
| 0.069 | 0.031 | 0.069 | Phosphodiesterase 1C inhibitor | |||
| 0.049 | 0.012 | 0.049 | Delayed rectifier potassium channel blocker | |||
| 0.042 | 0.005 | 0.042 | DNA polymerase III inhibitor | 0.03 0.015 DBMET03080 0.033 0.011 DBMET03081 | ||
| 0.175 | 0.139 | 0.363 | DNA damaging | 0.363 0.037 DBMET03081 | DBMET03081 | |
| 0.046 | 0.01 | 0.046 | Carnitine palmitoyltransferase inhibitor | 0.042 0.014 DBMET03081 | ||
| 0.076 | 0.041 | 0.076 | Alpha adrenoreceptor agonist | |||
| 0.063 | 0.028 | 0.063 | Glucosylceramidase inhibitor | 0.063 0.028 DBMET03081 | ||
| 0.096 | 0.061 | 0.096 | Phosphodiesterase 6D inhibitor | |||
| 0.059 | 0.025 | 0.088 | Bombesin 2 receptor antagonist | 0.088 0.016 DBMET03081 | DBMET03081 | |
| 0.087 | 0.054 | 0.087 | Acetylcholine M3 receptor agonist | |||
| 0.058 | 0.026 | 0.058 | Glucose-6-phosphate translocase inhibitor | 0.053 0.033 DBMET03081 | ||
| 0.05 | 0.019 | 0.05 | Dopamine D3 agonist | |||
| 0.061 | 0.03 | 0.061 | 5 Hydroxytryptamine 7 agonist | |||
| 0.107 | 0.076 | 0.145 | TRPA1 agonist | 0.145 0.035 DBMET03081 | DBMET03081 | |
| 0.042 | 0.011 | 0.092 | Lysophosphatidic acid 2 receptor antagonist | 0.092 0.005 DBMET03081 | DBMET03081 | |
| 0.061 | 0.032 | 0.061 | 5 Hydroxytryptamine 1 agonist | |||
| 0.056 | 0.027 | 0.056 | Potassium channel (Inward rectifier) blocker | |||
| 0.214 | 0.185 | 0.297 | Toll-Like receptor 7 agonist | 0.297 0.112 DBMET03081 | DBMET03081 | |
| 0.059 | 0.03 | 0.229 | Thromboxane synthase inhibitor | 0.229 0.003 DBMET03081 | DBMET03081 | |
| 0.096 | 0.067 | 0.096 | Chemokine receptor antagonist | |||
| 0.158 | 0.129 | 0.347 | Hypolipemic | 0.347 0.036 DBMET03081 | DBMET03081 | |
| 0.042 | 0.014 | 0.042 | Carnitine palmitoyltransferase 1 inhibitor | 0.035 0.022 DBMET03081 | ||
| 0.092 | 0.063 | 0.243 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.083 0.077 DBMET03080 0.243 0.01 DBMET03081 | DBMET03081 | |
| 0.07 | 0.042 | 0.07 | Exportin-1 inhibitor | |||
| 0.057 | 0.029 | 0.109 | Sphingosine 1-phosphate receptor 5 agonist | 0.109 0.007 DBMET03081 | DBMET03081 | |
| 0.058 | 0.031 | 0.058 | Melanin-concentrating hormone receptor 1 antagonist | |||
| 0.079 | 0.053 | 0.079 | CC chemokine receptor antagonist | |||
| 0.032 | 0.006 | 0.035 | 5 Hydroxytryptamine 4 agonist | 0.035 0.005 DBMET03080 | DBMET03080 | |
| 0.056 | 0.03 | 0.056 | Dopamine D4 agonist | |||
| 0.107 | 0.081 | 0.196 | Interleukin 8 antagonist | 0.196 0.014 DBMET03081 | DBMET03081 | |
| 0.076 | 0.05 | 0.105 | Vanilloid 4 agonist | 0.105 0.013 DBMET03081 | DBMET03081 | |
| 0.069 | 0.044 | 0.069 | Bcl2 antagonist | |||
| 0.061 | 0.036 | 0.119 | Sphingosine 1-phosphate receptor 3 antagonist | 0.119 0.005 DBMET03081 | DBMET03081 | |
| 0.043 | 0.018 | 0.066 | Leukotriene C4 antagonist | 0.066 0.005 DBMET03081 | DBMET03081 | |
| 0.034 | 0.009 | 0.034 | Myristoyl transferase inhibitor | |||
| 0.032 | 0.009 | 0.032 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.065 | 0.042 | 0.132 | Beta 3 adrenoreceptor antagonist | 0.132 0.008 DBMET03081 | DBMET03081 | |
| 0.103 | 0.08 | 0.103 | Nav1.5 sodium channel blocker | |||
| 0.06 | 0.036 | 0.06 | Alpha 1 adrenoreceptor agonist | |||
| 0.051 | 0.028 | 0.051 | 5 Hydroxytryptamine 1A agonist | |||
| 0.086 | 0.063 | 0.086 | Bromodomain-containing protein 2 inhibitor | |||
| 0.066 | 0.044 | 0.166 | Beta adrenoreceptor antagonist | 0.166 0.005 DBMET03081 | DBMET03081 | |
| 0.031 | 0.009 | 0.034 | Acid ceramidase inhibitor | 0.034 0.006 DBMET03081 | DBMET03081 | |
| 0.065 | 0.045 | 0.065 | Cannabinoid receptor agonist | |||
| 0.099 | 0.079 | 0.099 | Protein kinase C gamma inhibitor | |||
| 0.037 | 0.017 | 0.037 | Adenosine uptake inhibitor | |||
| 0.056 | 0.037 | 0.056 | Cannabinoid CB2 receptor agonist | |||
| 0.026 | 0.008 | 0.058 | Prostaglandin EP4 agonist | 0.058 0.005 DBMET03081 | DBMET03081 | |
| 0.105 | 0.087 | 0.105 | Estrogen antagonist | |||
| 0.102 | 0.084 | 0.107 | Proteasome inhibitor | 0.107 0.078 DBMET03081 | DBMET03081 | |
| 0.069 | 0.051 | 0.069 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.093 | 0.076 | 0.105 | Glutamate (mGluR7) agonist | 0.105 0.051 DBMET03081 | DBMET03081 | |
| 0.03 | 0.013 | 0.03 | CC chemokine 1 receptor antagonist | |||
| 0.103 | 0.087 | 0.167 | MAO inhibitor | 0.167 0.053 DBMET03080 | DBMET03080 | |
| 0.029 | 0.013 | 0.029 | Dopamine autoreceptor agonist | |||
| 0.073 | 0.057 | 0.073 | Analgesic, opioid | |||
| 0.055 | 0.04 | 0.141 | Beta 1 adrenoreceptor antagonist | 0.141 0.005 DBMET03081 | DBMET03081 | |
| 0.018 | 0.004 | 0.018 | DNA polymerase III polC-type inhibitor | 0.013 0.009 DBMET03080 0.014 0.007 DBMET03081 | ||
| 0.075 | 0.061 | 0.199 | Cell adhesion molecule inhibitor | 0.199 0.01 DBMET03081 | DBMET03081 | |
| 0.05 | 0.037 | 0.147 | Beta 2 adrenoreceptor antagonist | 0.147 0.005 DBMET03081 | DBMET03081 | |
| 0.04 | 0.028 | 0.04 | Phenylethanolamine N methyltransferase inhibitor | |||
| 0.02 | 0.008 | 0.02 | CXC chemokine 5 receptor antagonist | |||
| 0.182 | 0.17 | 0.182 | Prostaglandin dehydrogenase inhibitor | |||
| 0.084 | 0.072 | 0.084 | MAO B inhibitor | |||
| 0.022 | 0.011 | 0.022 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.141 | 0.129 | 0.266 | Non-steroidal antiinflammatory agent | 0.266 0.037 DBMET03081 | DBMET03081 | |
| 0.066 | 0.055 | 0.066 | Protein kinase C beta inhibitor | |||
| 0.101 | 0.09 | 0.166 | Caspase 3 inhibitor | 0.166 0.019 DBMET03081 | DBMET03081 | |
| 0.045 | 0.035 | 0.051 | Potassium channel Kv1.3 blocker | 0.051 0.028 DBMET03081 | DBMET03081 | |
| 0.034 | 0.024 | 0.067 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.067 0.005 DBMET03081 | DBMET03081 | |
| 0.1 | 0.09 | 0.249 | Cell adhesion inhibitor | 0.249 0.015 DBMET03081 | DBMET03081 | |
| 0.039 | 0.03 | 0.039 | Dopamine D5 agonist | |||
| 0.181 | 0.173 | 0.181 | Thyroid hormone beta antagonist | |||
| 0.082 | 0.074 | 0.088 | HIV-1 integrase (Overall Integration) inhibitor | 0.088 0.067 DBMET03081 | DBMET03081 | |
| 0.04 | 0.032 | 0.04 | Plasmepsin II inhibitor | 0.04 0.031 DBMET03081 | ||
| 0.044 | 0.036 | 0.058 | Adenosine deaminase inhibitor | 0.058 0.023 DBMET03081 | DBMET03081 | |
| 0.056 | 0.049 | 0.056 | Cyclin D1 inhibitor | |||
| 0.099 | 0.091 | 0.27 | Photosensitizer | 0.27 0.005 DBMET03081 | DBMET03081 | |
| 0.061 | 0.054 | 0.061 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.053 | 0.046 | 0.125 | Sphingosine 1-phosphate receptor 1 antagonist | 0.125 0.005 DBMET03081 | DBMET03081 | |
| 0.183 | 0.177 | 0.183 | Thyroid hormone antagonist | |||
| 0.025 | 0.019 | 0.029 | Sodium/glucose cotransporter inhibitor | 0.029 0.013 DBMET03081 | DBMET03081 | |
| 0.029 | 0.023 | 0.084 | Prostaglandin agonist | 0.084 0.006 DBMET03081 | DBMET03081 | |
| 0.035 | 0.029 | 0.078 | Glutamate (mGluR3) antagonist | 0.078 0.005 DBMET03081 | DBMET03081 | |
| 0.032 | 0.026 | 0.032 | Free fatty acid receptor 1 antagonist | 0.031 0.029 DBMET03081 | ||
| 0.048 | 0.043 | 0.048 | Toll-Like receptor 8 antagonist | |||
| 0.033 | 0.028 | 0.044 | Calcium-independent phospholipase A2 inhibitor | 0.044 0.006 DBMET03081 | DBMET03081 | |
| 0.056 | 0.052 | 0.056 | Phosphodiesterase 1A inhibitor | |||
| 0.026 | 0.022 | 0.026 | 5 Hydroxytryptamine 1D agonist | |||
| 0.015 | 0.011 | 0.044 | Thromboxane A2 agonist | 0.044 0.002 DBMET03081 | DBMET03081 | |
| 0.015 | 0.011 | 0.015 | NMDA receptor phencyclidine site antagonist | |||
| 0.026 | 0.023 | 0.026 | Hedgehog signaling activator | |||
| 0.186 | 0.183 | 0.274 | Transcription factor NF kappa B inhibitor | 0.274 0.11 DBMET03081 | DBMET03081 | |
| 0.031 | 0.028 | 0.031 | Vanilloid 4 antagonist | |||
| 0.049 | 0.046 | 0.067 | Alpha-mannosidase inhibitor | 0.067 0.019 DBMET03081 | DBMET03081 | |
| 0.036 | 0.034 | 0.036 | 5 Hydroxytryptamine 2B agonist | |||
| 0.045 | 0.043 | 0.045 | Dopamine beta hydroxylase inhibitor | |||
| 0.036 | 0.035 | 0.036 | Neurokinin 2 antagonist | |||
| 0.038 | 0.037 | 0.097 | Sphingosine 1-phosphate receptor 1 agonist | 0.097 0.005 DBMET03081 | DBMET03081 | |
| 0.09 | 0.089 | 0.146 | Cystathionine beta-synthase inhibitor | 0.146 0.043 DBMET03081 | DBMET03081 | |
| 0.04 | 0.039 | 0.04 | Alpha 1L adrenoreceptor agonist | |||
| 0.057 | 0.056 | 0.057 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.027 | 0.026 | 0.06 | Squalene synthetase inhibitor | 0.06 0.012 DBMET03081 | DBMET03081 | |
| 0.024 | 0.024 | 0.028 | Sodium/glucose cotransporter 2 inhibitor | 0.028 0.015 DBMET03081 | DBMET03081 | |
| 0.124 | 0.125 | 0.153 | Interferon gamma antagonist | 0.153 0.074 DBMET03081 | DBMET03081 | |
| 0.063 | 0.064 | 0.118 | Aminopeptidase I inhibitor | 0.118 0.02 DBMET03081 | DBMET03081 | |
| 0.031 | 0.032 | 0.033 | p53 inhibitor | 0.033 0.028 DBMET03081 | DBMET03081 | |
| 0.008 | 0.012 | 0.028 | Thromboxane agonist | 0.028 0.003 DBMET03081 | DBMET03081 | |
| 0.019 | 0.023 | 0.046 | Prostaglandin E2 agonist | 0.046 0.006 DBMET03081 | DBMET03081 | |
| 0.054 | 0.059 | 0.143 | Leukotriene antagonist | 0.143 0.011 DBMET03081 | DBMET03081 | |
| 0.069 | 0.074 | 0.161 | GABA B receptor agonist | 0.161 0.004 DBMET03081 | DBMET03081 | |
| 0.037 | 0.043 | 0.119 | Sphingosine 1-phosphate receptor agonist | 0.119 0.005 DBMET03081 | DBMET03081 | |
| 0.019 | 0.025 | 0.054 | Prostaglandin H2 antagonist | 0.054 0.003 DBMET03081 | DBMET03081 | |
| 0.076 | 0.082 | 0.079 | T cell inhibitor | 0.079 0.072 DBMET03081 | DBMET03081 | |
| 0.028 | 0.033 | 0.04 | Renin inhibitor | 0.04 0.023 DBMET03080 | DBMET03080 | |
| 0.019 | 0.024 | 0.058 | Beta 1 adrenoreceptor agonist | 0.058 0.004 DBMET03081 | DBMET03081 | |
| 0.073 | 0.079 | 0.093 | Opioid antagonist | 0.093 0.053 DBMET03080 | DBMET03080 | |
| 0.035 | 0.042 | 0.045 | Opioid kappa receptor agonist | 0.045 0.028 DBMET03080 | DBMET03080 | |
| 0.025 | 0.032 | 0.034 | Sirtuin 2 inhibitor | 0.034 0.022 DBMET03081 | DBMET03081 | |
| 0.116 | 0.123 | 0.247 | Hemostatic | 0.129 0.097 DBMET03080 0.247 0.022 DBMET03081 | DBMET03081 | |
| 0.086 | 0.094 | 0.094 | AMP-activated protein kinase stimulant | 0.094 0.079 DBMET03081 | DBMET03081 | |
| 0.024 | 0.032 | 0.058 | Sphingosine 1-phosphate receptor 3 agonist | 0.058 0.012 DBMET03081 | DBMET03081 | |
| 0.037 | 0.046 | 0.138 | Peroxisome proliferator-activated receptor alpha agonist | 0.138 0.007 DBMET03081 | DBMET03081 | |
| 0.015 | 0.024 | 0.062 | Prostaglandin EP2 agonist | 0.062 0.004 DBMET03081 | DBMET03081 | |
| 0.021 | 0.031 | 0.034 | Liver X receptor beta antagonist | 0.034 0.016 DBMET03081 | DBMET03081 | |
| 0.018 | 0.028 | 0.05 | Prostaglandin F2 alpha agonist | 0.05 0.004 DBMET03081 | DBMET03081 | |
| 0.082 | 0.093 | 0.115 | Nitric-oxide synthase inhibitor | 0.115 0.042 DBMET03081 | DBMET03081 | |
| 0.082 | 0.093 | 0.131 | Electrolyte absorption antagonist | 0.131 0.029 DBMET03081 | DBMET03081 | |
| 0.062 | 0.074 | 0.077 | Glycine receptor agonist | 0.077 0.043 DBMET03081 | DBMET03081 | |
| 0.156 | 0.168 | 0.349 | Hypoglycemic | 0.349 0.038 DBMET03081 | DBMET03081 | |
| 0.036 | 0.049 | 0.067 | Mannosidase inhibitor | 0.067 0.013 DBMET03081 | DBMET03081 | |
| 0.058 | 0.073 | 0.107 | Cathepsin G inhibitor | 0.107 0.031 DBMET03081 | DBMET03081 | |
| 0.051 | 0.067 | 0.083 | Nitric oxide donor | 0.083 0.02 DBMET03081 | DBMET03081 | |
| 0.074 | 0.089 | 0.209 | Aminopeptidase B inhibitor | 0.209 0.019 DBMET03081 | DBMET03081 | |
| 0.058 | 0.074 | 0.094 | Glutamate (mGluR6) antagonist | 0.094 0.013 DBMET03081 | DBMET03081 | |
| 0.023 | 0.039 | 0.066 | Kainate receptor 2 antagonist | 0.066 0.01 DBMET03081 | DBMET03081 | |
| 0.009 | 0.027 | 0.033 | G-protein-coupled receptor 120 agonist | 0.033 0.005 DBMET03081 | DBMET03081 | |
| 0.078 | 0.096 | 0.155 | Interleukin 1 beta converting enzyme inhibitor | 0.155 0.015 DBMET03081 | DBMET03081 | |
| 0.026 | 0.044 | 0.074 | NMDA receptor subunit 3A antagonist | 0.074 0.013 DBMET03081 | DBMET03081 | |
| 0.084 | 0.102 | 0.156 | Adenylate cyclase inhibitor | 0.156 0.041 DBMET03081 | DBMET03081 | |
| 0.032 | 0.05 | 0.099 | Glycine transporter 2 inhibitor | 0.099 0.013 DBMET03081 | DBMET03081 | |
| 0.061 | 0.08 | 0.159 | GABA aminotransferase inhibitor | 0.159 0.006 DBMET03081 | DBMET03081 | |
| 0.023 | 0.044 | 0.039 | ATP citrate lysase inhibitor | 0.039 0.014 DBMET03081 | DBMET03081 | |
| 0.094 | 0.114 | 0.208 | Bone formation stimulant | 0.208 0.034 DBMET03081 | DBMET03081 | |
| 0.021 | 0.042 | 0.057 | Arginase inhibitor | 0.057 0.012 DBMET03081 | DBMET03081 | |
| 0.017 | 0.038 | 0.063 | Prostaglandin EP4 antagonist | 0.063 0.007 DBMET03081 | DBMET03081 | |
| 0.021 | 0.042 | 0.047 | Prostaglandin D2 agonist | 0.047 0.009 DBMET03081 | DBMET03081 | |
| 0.03 | 0.052 | 0.044 | Purinergic P2Y antagonist | 0.044 0.032 DBMET03081 | DBMET03081 | |
| 0.073 | 0.097 | 0.107 | Vanilloid agonist | 0.107 0.027 DBMET03081 | DBMET03081 | |
| 0.03 | 0.055 | 0.073 | NMDA receptor subunit 3B antagonist | 0.073 0.015 DBMET03081 | DBMET03081 | |
| 0.065 | 0.093 | 0.115 | Sphingosine 1-phosphate receptor antagonist | 0.115 0.014 DBMET03081 | DBMET03081 | |
| 0.026 | 0.055 | 0.038 | Oxytocin agonist | 0.038 0.034 DBMET03081 | DBMET03081 | |
| 0.008 | 0.037 | 0.016 | Integrin alphaVbeta6 antagonist | 0.016 0.008 DBMET03081 | DBMET03081 | |
| 0.07 | 0.1 | 0.079 | Interleukin 5 antagonist | 0.079 0.076 DBMET03081 | DBMET03081 | |
| 0.032 | 0.063 | 0.054 | Metalloproteinase-3 inhibitor | 0.054 0.029 DBMET03081 | DBMET03081 | |
| 0.018 | 0.05 | 0.026 | LFA antagonist | 0.026 0.022 DBMET03081 | DBMET03081 | |
| 0.076 | 0.108 | 0.104 | Anabolic | 0.104 0.057 DBMET03081 | DBMET03081 | |
| 0.04 | 0.073 | 0.056 | Matrix metalloproteinase (membrane-type) inhibitor | 0.056 0.037 DBMET03081 | DBMET03081 | |
| 0.017 | 0.05 | 0.043 | Lysophosphatidic acid receptor 1 agonist | 0.043 0.005 DBMET03081 | DBMET03081 | |
| 0.007 | 0.041 | 0.021 | Prostacyclin agonist | 0.021 0.008 DBMET03081 | DBMET03081 | |
| 0.061 | 0.095 | 0.102 | Glycine receptor antagonist | 0.102 0.031 DBMET03081 | DBMET03081 | |
| 0.043 | 0.079 | 0.078 | Opioid mu receptor antagonist | 0.078 0.041 DBMET03080 | DBMET03080 | |
| 0.075 | 0.113 | 0.109 | Bile acid receptor antagonist | 0.109 0.032 DBMET03081 | DBMET03081 | |
| 0.042 | 0.08 | 0.086 | Neutrophil collagenase inhibitor | 0.086 0.028 DBMET03081 | DBMET03081 | |
| 0.018 | 0.056 | 0.073 | Peroxisome proliferator-activated receptor delta agonist | 0.073 0.008 DBMET03081 | DBMET03081 | |
| 0.013 | 0.052 | 0.028 | Leukotriene D4 antagonist | 0.028 0.016 DBMET03081 | DBMET03081 | |
| 0.02 | 0.059 | 0.046 | Phosphoglycerate kinase inhibitor | 0.046 0.015 DBMET03081 | DBMET03081 | |
| 0.068 | 0.109 | 0.087 | NADH dehydrogenase inhibitor | 0.087 0.061 DBMET03081 | DBMET03081 | |
| 0.076 | 0.117 | 0.175 | Chelator | 0.175 0.029 DBMET03081 | DBMET03081 | |
| 0.032 | 0.074 | 0.054 | Glutamate (mGluR4) antagonist | 0.054 0.017 DBMET03081 | DBMET03081 | |
| 0.038 | 0.08 | 0.078 | Carbamoyl phosphate synthetase inhibitor | 0.078 0.03 DBMET03081 | DBMET03081 | |
| 0.145 | 0.187 | 0.197 | Calpain inhibitor | 0.197 0.116 DBMET03081 | DBMET03081 | |
| 0.042 | 0.085 | 0.128 | Peroxisome proliferator-activated receptor gamma agonist | 0.128 0.018 DBMET03081 | DBMET03081 | |
| 0.004 | 0.048 | 0.016 | Beta 3 adrenoreceptor agonist | 0.016 0.005 DBMET03081 | DBMET03081 | |
| 0.037 | 0.081 | 0.08 | Leukotriene B4 antagonist | 0.08 0.015 DBMET03081 | DBMET03081 | |
| 0.111 | 0.156 | 0.156 | Melanin inhibitor | 0.156 0.074 DBMET03081 | DBMET03081 | |
| 0.011 | 0.057 | 0.027 | Integrin alphaVbeta1 antagonist | 0.027 0.007 DBMET03081 | DBMET03081 | |
| 0.005 | 0.051 | 0.029 | Peroxisome proliferator-activated receptor alpha antagonist | 0.029 0.012 DBMET03081 | DBMET03081 | |
| 0.022 | 0.069 | 0.042 | Peroxisome proliferator-activated receptor delta antagonist | 0.042 0.013 DBMET03081 | DBMET03081 | |
| 0.078 | 0.125 | 0.178 | Amylase inhibitor | 0.178 0.052 DBMET03081 | DBMET03081 | |
| 0.032 | 0.08 | 0.089 | Lysophosphatidic acid 3 receptor antagonist | 0.089 0.007 DBMET03081 | DBMET03081 | |
| 0.016 | 0.065 | 0.028 | Calcium-sensing receptor agonist | 0.028 0.016 DBMET03081 | DBMET03081 | |
| 0.017 | 0.068 | 0.035 | Calcitonin receptor agonist | 0.035 0.023 DBMET03081 | DBMET03081 | |
| 0.027 | 0.079 | 0.072 | Opioid agonist | 0.072 0.022 DBMET03080 | DBMET03080 | |
| 0.209 | 0.261 | 0.301 | Apoptosis agonist | 0.301 0.171 DBMET03081 | DBMET03081 | |
| 0.121 | 0.174 | 0.334 | Insulin sensitizer | 0.334 0.011 DBMET03081 | DBMET03081 | |
| 0.004 | 0.058 | 0.019 | Integrin alpha4beta1 antagonist | 0.019 0.01 DBMET03081 | DBMET03081 | |
| 0.041 | 0.095 | 0.099 | Leukotriene synthesis inhibitor | 0.099 0.027 DBMET03081 | DBMET03081 | |
| 0.09 | 0.145 | 0.166 | Protein kinase stimulant | 0.166 0.058 DBMET03081 | DBMET03081 | |
| 0.026 | 0.081 | 0.06 | Geranyltranstransferase inhibitor | 0.06 0.014 DBMET03081 | DBMET03081 | |
| 0.054 | 0.11 | 0.097 | Peroxisome proliferator-activated receptor gamma antagonist | 0.097 0.017 DBMET03081 | DBMET03081 | |
| 0.013 | 0.068 | 0.048 | Lysine carboxypeptidase inhibitor | 0.048 0.008 DBMET03081 | DBMET03081 | |
| 0.072 | 0.132 | 0.113 | Carbonic anhydrase XV inhibitor | 0.113 0.052 DBMET03081 | DBMET03081 | |
| 0.021 | 0.082 | 0.033 | Carboxypeptidase B inhibitor | 0.033 0.024 DBMET03081 | DBMET03081 | |
| 0.059 | 0.121 | 0.18 | Glutathione S-transferase inhibitor | 0.18 0.007 DBMET03081 | DBMET03081 | |
| 0.029 | 0.091 | 0.133 | Prostaglandin EP2 antagonist | 0.133 0.012 DBMET03081 | DBMET03081 | |
| 0.071 | 0.135 | 0.092 | Interleukin 12 antagonist | 0.092 0.069 DBMET03081 | DBMET03081 | |
| 0.078 | 0.144 | 0.15 | Alpha-N-acetylglucosaminidase inhibitor | 0.15 0.055 DBMET03081 | DBMET03081 | |
| 0.038 | 0.106 | 0.119 | Phenylalanine 4-hydroxylase inhibitor | 0.119 0.018 DBMET03081 | DBMET03081 | |
| 0.011 | 0.079 | 0.032 | Lysophosphatidic acid 1 receptor antagonist | 0.032 0.006 DBMET03081 | DBMET03081 | |
| 0.021 | 0.09 | 0.045 | Integrin alpha5beta1 antagonist | 0.045 0.023 DBMET03081 | DBMET03081 | |
| 0.064 | 0.134 | 0.135 | Ferrochelatase inhibitor | 0.135 0.044 DBMET03081 | DBMET03081 | |
| 0.096 | 0.167 | 0.203 | Insulin secretagoues | 0.203 0.034 DBMET03081 | DBMET03081 | |
| 0.048 | 0.119 | 0.202 | Ornithine decarboxylase inhibitor | 0.202 0.005 DBMET03081 | DBMET03081 | |
| 0.009 | 0.08 | 0.023 | Purinergic P2Y12 antagonist | 0.023 0.016 DBMET03081 | DBMET03081 | |
| 0.021 | 0.092 | 0.055 | Ribonucleoside-diphosphate reductase inhibitor | 0.055 0.037 DBMET03081 | DBMET03081 | |
| 0.069 | 0.141 | 0.499 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.499 0.005 DBMET03080 | DBMET03080 | |
| 0.015 | 0.087 | 0.025 | Integrin alpha2beta1 antagonist | 0.025 0.02 DBMET03081 | DBMET03081 | |
| 0.024 | 0.096 | 0.045 | AMPA 4 receptor antagonist | 0.045 0.019 DBMET03081 | DBMET03081 | |
| 0.02 | 0.094 | 0.073 | Phosphorylase inhibitor | 0.073 0.019 DBMET03081 | DBMET03081 | |
| 0.02 | 0.094 | 0.059 | Ribonucleotide reductase inhibitor | 0.059 0.037 DBMET03081 | DBMET03081 | |
| 0.065 | 0.14 | 0.087 | Estrogen-related receptor beta agonist | 0.087 0.048 DBMET03081 | DBMET03081 | |
| 0.054 | 0.129 | 0.102 | Inducible nitric-oxide synthase inhibitor | 0.102 0.035 DBMET03081 | DBMET03081 | |
| 0.025 | 0.101 | 0.058 | Dihydrofolate reductase inhibitor | 0.058 0.011 DBMET03081 | DBMET03081 | |
| 0.047 | 0.123 | 0.083 | Metalloproteinase-2 inhibitor | 0.083 0.05 DBMET03081 | DBMET03081 | |
| 0.01 | 0.087 | 0.049 | Prostacyclin antagonist | 0.049 0.013 DBMET03081 | DBMET03081 | |
| 0.163 | 0.244 | 0.36 | Apoptosis antagonist | 0.36 0.051 DBMET03081 | DBMET03081 | |
| 0.014 | 0.094 | 0.039 | Thyroid hormone agonist | 0.039 0.007 DBMET03081 | DBMET03081 | |
| 0.037 | 0.119 | 0.05 | Angiotensin-converting enzyme inhibitor | 0.05 0.048 DBMET03081 | DBMET03081 | |
| 0.058 | 0.143 | 0.138 | Triose-phosphate isomerase inhibitor | 0.138 0.024 DBMET03081 | DBMET03081 | |
| 0.075 | 0.162 | 0.12 | Lipid peroxidase inhibitor | 0.12 0.094 DBMET03081 | DBMET03081 | |
| 0.066 | 0.155 | 0.198 | Alkylator | 0.198 0.027 DBMET03081 | DBMET03081 | |
| 0.095 | 0.185 | 0.219 | Platelet adhesion inhibitor | 0.219 0.061 DBMET03081 | DBMET03081 | |
| 0.033 | 0.123 | 0.085 | Lipase inhibitor | 0.085 0.038 DBMET03081 | DBMET03081 | |
| 0.013 | 0.104 | 0.054 | Kainate receptor antagonist | 0.054 0.019 DBMET03081 | DBMET03081 | |
| 0.027 | 0.119 | 0.042 | VCAM-1 antagonist | 0.042 0.019 DBMET03081 | DBMET03081 | |
| 0.027 | 0.119 | 0.042 | VCAM antagonist | 0.042 0.019 DBMET03081 | DBMET03081 | |
| 0.021 | 0.113 | 0.045 | Fructose-1,6-bisphosphatase inhibitor | 0.045 0.031 DBMET03081 | DBMET03081 | |
| 0.008 | 0.103 | 0.038 | Leukotriene B4 receptor 1 antagonist | 0.038 0.013 DBMET03081 | DBMET03081 | |
| 0.021 | 0.116 | 0.049 | Prostaglandin E2 antagonist | 0.049 0.037 DBMET03081 | DBMET03081 | |
| 0.02 | 0.115 | 0.044 | Integrin alpha2 antagonist | 0.044 0.017 DBMET03081 | DBMET03081 | |
| 0.028 | 0.124 | 0.053 | Glucose-6-phosphate isomerase inhibitor | 0.053 0.026 DBMET03081 | DBMET03081 | |
| 0.051 | 0.148 | 0.149 | Alcohol dehydrogenase inhibitor | 0.149 0.02 DBMET03081 | DBMET03081 | |
| 0.004 | 0.106 | 0.049 | Microsomal triglyceride transfer protein inhibitor | 0.049 0.004 DBMET03080 | DBMET03080 | |
| 0.022 | 0.126 | 0.037 | Glutamate (mGluR8) antagonist | 0.037 0.023 DBMET03081 | DBMET03081 | |
| 0.005 | 0.11 | 0.02 | Prostaglandin D2 antagonist | 0.02 0.019 DBMET03081 | DBMET03081 | |
| 0.025 | 0.13 | 0.041 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.041 0.031 DBMET03081 | DBMET03081 | |
| 0.016 | 0.122 | 0.133 | Toll-Like receptor 2 agonist | 0.133 0.012 DBMET03081 | DBMET03081 | |
| 0.019 | 0.125 | 0.099 | Prostaglandin antagonist | 0.099 0.018 DBMET03081 | DBMET03081 | |
| 0.006 | 0.112 | 0.029 | Prostaglandin EP3 antagonist | 0.029 0.023 DBMET03081 | DBMET03081 | |
| 0.026 | 0.133 | 0.038 | Integrin alpha1beta1 antagonist | 0.038 0.026 DBMET03081 | DBMET03081 | |
| 0.055 | 0.162 | 0.259 | GABA C receptor agonist | 0.259 0.013 DBMET03081 | DBMET03081 | |
| 0.004 | 0.114 | 0.039 | AMPA 1 receptor antagonist | 0.039 0.015 DBMET03081 | DBMET03081 | |
| 0.04 | 0.153 | 0.084 | Telomerase inhibitor | 0.084 0.042 DBMET03080 | DBMET03080 | |
| 0.008 | 0.125 | 0.036 | AMPA 3 receptor antagonist | 0.036 0.016 DBMET03081 | DBMET03081 | |
| 0.056 | 0.174 | 0.101 | Thioredoxin inhibitor | 0.101 0.047 DBMET03081 | DBMET03081 | |
| 0.004 | 0.122 | 0.011 | Calcium-dependent phospholipase A2 inhibitor | 0.011 0.01 DBMET03081 | DBMET03081 | |
| 0.024 | 0.142 | 0.091 | Selectin antagonist | 0.091 0.031 DBMET03081 | DBMET03081 | |
| 0.077 | 0.195 | 0.182 | Anticoagulant | 0.182 0.06 DBMET03081 | DBMET03081 | |
| 0.011 | 0.129 | 0.031 | Fumarate hydratase inhibitor | 0.031 0.027 DBMET03081 | DBMET03081 | |
| 0.021 | 0.139 | 0.053 | Acyl-CoA dehydrogenase inhibitor | 0.053 0.039 DBMET03081 | DBMET03081 | |
| 0.015 | 0.133 | 0.067 | Carbonic anhydrase VB inhibitor | 0.067 0.029 DBMET03081 | DBMET03081 | |
| 0.004 | 0.123 | 0.021 | Integrin alpha4 antagonist | 0.021 0.02 DBMET03081 | DBMET03081 | |
| 0.087 | 0.209 | 0.345 | Growth hormone agonist | 0.345 0.024 DBMET03081 | DBMET03081 | |
| 0.004 | 0.13 | 0.022 | VLA-4 antagonist | 0.022 0.02 DBMET03081 | DBMET03081 | |
| 0.017 | 0.144 | 0.036 | Cholecystokinin B agonist | 0.036 0.028 DBMET03081 | DBMET03081 | |
| 0.028 | 0.155 | 0.066 | Heparanase inhibitor | 0.066 0.015 DBMET03081 | DBMET03081 | |
| 0.032 | 0.165 | 0.206 | NMDA receptor agonist | 0.206 0.004 DBMET03081 | DBMET03081 | |
| 0.055 | 0.19 | 0.093 | GABA C receptor antagonist | 0.093 0.089 DBMET03081 | DBMET03081 | |
| 0.031 | 0.166 | 0.106 | Glutamate decarboxylase inhibitor | 0.106 0.027 DBMET03081 | DBMET03081 | |
| 0.064 | 0.202 | 0.213 | Aldehyde dehydrogenase inhibitor | 0.213 0.025 DBMET03081 | DBMET03081 | |
| 0.022 | 0.161 | 0.129 | Phosphofructokinase-1 inhibitor | 0.129 0.023 DBMET03081 | DBMET03081 | |
| 0.03 | 0.169 | 0.051 | CD45 antagonist | 0.051 0.032 DBMET03081 | DBMET03081 | |
| 0.041 | 0.181 | 0.119 | Carbonic anhydrase VI inhibitor | 0.119 0.03 DBMET03081 | DBMET03081 | |
| 0.004 | 0.145 | 0.016 | Carbonic anhydrase X inhibitor | 0.016 0.013 DBMET03081 | DBMET03081 | |
| 0.004 | 0.145 | 0.016 | Carbonic anhydrase VIII inhibitor | 0.016 0.013 DBMET03081 | DBMET03081 | |
| 0.02 | 0.162 | 0.1 | NMDA receptor glycine site agonist | 0.1 0.016 DBMET03081 | DBMET03081 | |
| 0.03 | 0.176 | 0.106 | Phosphodiesterase IV inhibitor | 0.106 0.041 DBMET03080 | DBMET03080 | |
| 0.052 | 0.198 | 0.091 | GABA C receptor rho-1 antagonist | 0.091 0.076 DBMET03081 | DBMET03081 | |
| 0.024 | 0.172 | 0.045 | Glucagon-like peptide 1 receptor antagonist | 0.045 0.018 DBMET03081 | DBMET03081 | |
| 0.005 | 0.156 | 0.055 | GP IIb/IIIa receptor antagonist | 0.055 0.03 DBMET03081 | DBMET03081 | |
| 0.061 | 0.213 | 0.164 | Adenylate kinase inhibitor | 0.164 0.022 DBMET03081 | DBMET03081 | |
| 0.01 | 0.161 | 0.08 | Integrin antagonist | 0.08 0.02 DBMET03081 | DBMET03081 | |
| 0.052 | 0.204 | 0.121 | Carbonic anhydrase III inhibitor | 0.121 0.043 DBMET03081 | DBMET03081 | |
| 0.008 | 0.161 | 0.066 | Complement C3a chemotactic receptor antagonist | 0.066 0.019 DBMET03081 | DBMET03081 | |
| 0.065 | 0.218 | 0.194 | Folate antagonist | 0.194 0.011 DBMET03081 | DBMET03081 | |
| 0.003 | 0.157 | 0.016 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.016 0.009 DBMET03081 | DBMET03081 | |
| 0.11 | 0.265 | 0.216 | Lipoxygenase inhibitor | 0.216 0.125 DBMET03081 | DBMET03081 | |
| 0.01 | 0.17 | 0.095 | Antimetabolite | 0.095 0.017 DBMET03081 | DBMET03081 | |
| 0.02 | 0.184 | 0.077 | Glucagon-like peptide 1 agonist | 0.077 0.037 DBMET03081 | DBMET03081 | |
| 0.015 | 0.179 | 0.044 | Carbonic anhydrase XIV inhibitor | 0.044 0.04 DBMET03081 | DBMET03081 | |
| 0.015 | 0.179 | 0.054 | Membrane dipeptidase inhibitor | 0.054 0.013 DBMET03081 | DBMET03081 | |
| 0.123 | 0.296 | 0.254 | Immunomodulator | 0.254 0.112 DBMET03080 0.201 0.163 DBMET03081 | DBMET03080 | |
| 0.021 | 0.195 | 0.063 | Aconitate hydratase inhibitor | 0.063 0.023 DBMET03081 | DBMET03081 | |
| 0.022 | 0.199 | 0.141 | Catalase inhibitor | 0.141 0.028 DBMET03081 | DBMET03081 | |
| 0.025 | 0.204 | 0.079 | Botulinum neurotoxin type A inhibitor | 0.079 0.017 DBMET03081 | DBMET03081 | |
| 0.023 | 0.206 | 0.065 | Porphobilinogen synthase inhibitor | 0.065 0.062 DBMET03081 | DBMET03081 | |
| 0.049 | 0.236 | 0.095 | ABCA1 expression enhancer | 0.095 0.058 DBMET03081 | DBMET03081 | |
| 0.007 | 0.193 | 0.015 | Integrin beta6 antagonist | 0.015 0.008 DBMET03081 | DBMET03081 | |
| 0.022 | 0.213 | 0.077 | Carbonic anhydrase VA inhibitor | 0.077 0.039 DBMET03081 | DBMET03081 | |
| 0.014 | 0.205 | 0.036 | Erythropoietin receptor agonist | 0.036 0.033 DBMET03081 | DBMET03081 | |
| 0.017 | 0.211 | 0.04 | AICAR transformylase inhibitor | 0.04 0.038 DBMET03081 | DBMET03081 | |
| 0.072 | 0.268 | 0.363 | Interleukin antagonist | 0.363 0.037 DBMET03081 | DBMET03081 | |
| 0.082 | 0.279 | 0.638 | Tumour necrosis factor alpha release inhibitor | 0.638 0.005 DBMET03080 | DBMET03080 | |
| 0.033 | 0.231 | 0.1 | Glutamate dehydrogenase inhibitor | 0.1 0.031 DBMET03081 | DBMET03081 | |
| 0.108 | 0.306 | 0.245 | DNA synthesis inhibitor | 0.245 0.07 DBMET03081 | DBMET03081 | |
| 0.026 | 0.226 | 0.094 | Prostaglandin F2 alpha antagonist | 0.094 0.014 DBMET03081 | DBMET03081 | |
| 0.005 | 0.207 | 0.055 | Carbonic anhydrase IV inhibitor | 0.055 0.022 DBMET03081 | DBMET03081 | |
| 0.029 | 0.233 | 0.082 | Potassium channel (Ca-activated) activator | 0.082 0.073 DBMET03081 | DBMET03081 | |
| 0.13 | 0.337 | 0.19 | Caspase 3 stimulant | 0.19 0.185 DBMET03081 | DBMET03081 | |
| 0.018 | 0.227 | 0.068 | Carbonic anhydrase V inhibitor | 0.068 0.045 DBMET03081 | DBMET03081 | |
| 0.008 | 0.224 | 0.049 | Dihydropteroate synthase inhibitor | 0.049 0.018 DBMET03081 | DBMET03081 | |
| 0.075 | 0.291 | 0.172 | Free radical scavenger | 0.172 0.122 DBMET03081 | DBMET03081 | |
| 0.011 | 0.228 | 0.039 | Macrophage elastase inhibitor | 0.039 0.035 DBMET03081 | DBMET03081 | |
| 0.043 | 0.264 | 0.154 | DNA polymerase I inhibitor | 0.154 0.047 DBMET03081 | DBMET03081 | |
| 0.014 | 0.235 | 0.052 | Argininosuccinate synthase inhibitor | 0.052 0.045 DBMET03081 | DBMET03081 | |
| 0.006 | 0.233 | 0.023 | Integrin alphaVbeta3 antagonist | 0.023 0.014 DBMET03081 | DBMET03081 | |
| 0.023 | 0.256 | 0.079 | Topoisomerase II alpha inhibitor | 0.079 0.054 DBMET03081 | DBMET03081 | |
| 0.005 | 0.239 | 0.042 | Glucagon receptor antagonist | 0.042 0.013 DBMET03081 | DBMET03081 | |
| 0.009 | 0.244 | 0.07 | Ornithine carbamoyltransferase inhibitor | 0.07 0.026 DBMET03081 | DBMET03081 | |
| 0.05 | 0.289 | 0.314 | Angiogenesis stimulant | 0.314 0.044 DBMET03081 | DBMET03081 | |
| 0.075 | 0.319 | 0.179 | Antioxidant | 0.179 0.133 DBMET03081 | DBMET03081 | |
| 0.053 | 0.304 | 0.108 | Interleukin 4 antagonist | 0.108 0.104 DBMET03081 | DBMET03081 | |
| 0.061 | 0.313 | 0.122 | Factor V inhibitor | 0.122 0.037 DBMET03081 | DBMET03081 | |
| 0.063 | 0.328 | 0.177 | Interleukin 6 antagonist | 0.177 0.057 DBMET03081 | DBMET03081 | |
| 0.02 | 0.287 | 0.067 | CDC25A inhibitor | 0.067 0.062 DBMET03081 | DBMET03081 | |
| 0.061 | 0.341 | 0.153 | Hepatoprotectant | 0.153 0.107 DBMET03081 | DBMET03081 | |
| 0.03 | 0.324 | 0.101 | Mucolytic | 0.101 0.076 DBMET03081 | DBMET03081 | |
| 0.038 | 0.338 | 0.113 | Nav1.4 sodium channel blocker | 0.113 0.059 DBMET03081 | DBMET03081 | |
| 0.029 | 0.333 | 0.058 | Caspase 9 inhibitor | 0.058 0.051 DBMET03081 | DBMET03081 | |
| 0.025 | 0.343 | 0.113 | DNA intercalator | 0.113 0.062 DBMET03080 | DBMET03080 | |
| 0.011 | 0.33 | 0.057 | Plasminogen activator inhibitor antagonist | 0.057 0.025 DBMET03081 | DBMET03081 | |
| 0.029 | 0.375 | 0.231 | Thrombolytic | 0.231 0.039 DBMET03081 | DBMET03081 | |
| 0.043 | 0.395 | 0.093 | Hematopoietic | 0.093 0.044 DBMET03081 | DBMET03081 | |
| 0.026 | 0.38 | 0.092 | Aminoacyl-tRNA synthetase inhibitor | 0.092 0.056 DBMET03081 | DBMET03081 | |
| 0.067 | 0.44 | 0.183 | Lipocortins synthesis antagonist | 0.183 0.068 DBMET03081 | DBMET03081 | |
| 0.012 | 0.388 | 0.097 | Protein-tyrosine phosphatase 1B inhibitor | 0.097 0.081 DBMET03081 | DBMET03081 | |
| 0.023 | 0.417 | 0.143 | Protein-tyrosine phosphatase inhibitor | 0.143 0.086 DBMET03081 | DBMET03081 | |
| 0.037 | 0.431 | 0.079 | Transcription factor NF kappa B stimulant | 0.079 0.072 DBMET03081 | DBMET03081 | |
| 0.039 | 0.453 | 0.143 | Histone deacetylase SIRT1 inhibitor | 0.143 0.068 DBMET03081 | DBMET03081 | |
| 0.089 | 0.514 | 0.306 | Peptidyltransferase inhibitor | 0.306 0.022 DBMET03081 | DBMET03081 | |
| 0.021 | 0.463 | 0.126 | Histone deacetylase class III inhibitor | 0.126 0.064 DBMET03081 | DBMET03081 | |
| 0.053 | 0.616 | 0.307 | Sodium/bile acid cotransporter inhibitor | 0.307 0.073 DBMET03081 | DBMET03081 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |